Cargando…

Prognostic value of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in multiple myeloma patients treated with thalidomide-based regimen

Neutrophils to lymphocytes ratio (NLR) and platelets to lymphocytes ratio (PLR) are considered as laboratory markers of inflammation. They can be potentially useful in predicting the course of multiple neoplasms including selected hematological cancers. The aim of the study was to assess the value o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szudy-Szczyrek, Aneta, Mlak, Radosław, Mielnik, Michał, Szczyrek, Michał, Nowaczyńska, Aleksandra, Homa-Mlak, Iwona, Zmorzyński, Szymon, Kuśmierczuk, Kinga, Sompor, Jacek, Filip, Agata, Małecka-Massalska, Teresa, Hus, Marek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683474/ https://www.ncbi.nlm.nih.gov/pubmed/32458064 http://dx.doi.org/10.1007/s00277-020-04092-5

Ejemplares similares

The Clinical Relevance of Selected Cytokines in Newly Diagnosed Multiple Myeloma Patients
por: Mielnik, Michał, et al.
Publicado: (2023)

Neutrophil-to-Lymphocyte Ratio as a Factor Predicting Radiotherapy Induced Oral Mucositis in Head Neck Cancer Patients Treated with Radiotherapy
por: Homa-Mlak, Iwona, et al.
Publicado: (2021)

Circulating Serum MiRNA-8074 as a Novel Prognostic Biomarker for Multiple Myeloma
por: Szudy-Szczyrek, Aneta, et al.
Publicado: (2022)

Polymorphisms in the promoter region of the CRBN gene as a predictive factor for the first-line CTD therapy in multiple myeloma patients
por: Szudy-Szczyrek, Aneta, et al.
Publicado: (2018)

The TT Genotype of the KIAA1524 rs2278911 Polymorphism Is Associated with Poor Prognosis in Multiple Myeloma
por: Szudy-Szczyrek, Aneta, et al.
Publicado: (2023)

Polymorphisms in the Gene Encoding Caspase 8 May Predict the Response to First-Line Platinum-Based Chemotherapy in Locally Advanced or Advanced Non-Small-Cell Lung Cancer
por: Szczyrek, Michał, et al.
Publicado: (2021)

Polymorphism of Baculoviral Inhibitor of Apoptosis Repeat-Containing 5 (BIRC5) Can Be Associated with Clinical Outcome of Non-Small Cell Lung Cancer
por: Szczyrek, Michał, et al.
Publicado: (2022)

High Level of Irisin as a Marker of Malnutrition in Head and Neck Cancer Patients Subjected to Radiotherapy
por: Homa-Mlak, Iwona, et al.
Publicado: (2022)

Polymorphisms of Genes Encoding Multidrug Resistance Proteins as a Predictive Factor for Second-Line Docetaxel Therapy in Advanced Non-small Cell Lung Cancer
por: Szczyrek, Michał, et al.
Publicado: (2016)

MiRNA as a Potential Target for Multiple Myeloma Therapy–Current Knowledge and Perspectives
por: Szudy-Szczyrek, Aneta, et al.
Publicado: (2022)

Electrical Changes in Polish Patients with Chronic Heart Failure: Preliminary Observations
por: Sobieszek, Grzegorz, et al.
Publicado: (2019)

Methylation of DROSHA and DICER as a Biomarker for the Detection of Lung Cancer
por: Szczyrek, Michał, et al.
Publicado: (2021)

Association between myostatin serum concentration and body fat level in peri- and postmenopausal women
por: Bojar, Iwona, et al.
Publicado: (2021)

Three Pathways of Cancer Cachexia: Inflammation, Changes in Adipose Tissue and Loss of Muscle Mass—The Role of miRNAs
por: Homa-Mlak, Iwona, et al.
Publicado: (2022)

Chemotherapy-Related Differences in Cognitive Functioning and Their Biological Predictors in Patients with Multiple Myeloma
por: Bury-Kamińska, Magdalena, et al.
Publicado: (2021)

ACE Insertion/Deletion Polymorphism (rs4646994) Is Associated With the Increased Risk of Multiple Myeloma
por: Zmorzynski, Szymon, et al.
Publicado: (2019)

The Relationship of CCL5 and CCR1 Variants with Response Rate and Survival Taking into Account Thalidomide/Bortezomib Treatment in Patients with Multiple Myeloma
por: Popek-Marciniec, Sylwia, et al.
Publicado: (2023)

Therapeutic Potential of Innate Lymphoid Cells for Multiple Myeloma Therapy
por: Szudy-Szczyrek, Aneta, et al.
Publicado: (2021)

Etiopathogenesis and Diagnostic Strategies in Autoimmune Hepatitis
por: Domerecka, Weronika, et al.
Publicado: (2021)

The Association of GSTT1, GSTM1, and TNF-α Polymorphisms With the Risk and Outcome in Multiple Myeloma
por: Zmorzyński, Szymon, et al.
Publicado: (2019)

The impact of ACE gene polymorphism on the incidence and phenotype of sarcoidosis in rural and urban settings
por: Kieszko, Robert, et al.
Publicado: (2015)

Polymorphism of Promoter Region of TNFRSF1A Gene (−610 T > G) as a Novel Predictive Factor for Radiotherapy Induced Oral Mucositis in HNC Patients
por: Brzozowska, Anna, et al.
Publicado: (2017)

Polymorphism of regulatory region of APEH gene (c.-521G>C, rs4855883) as a relevant predictive factor for radiotherapy induced oral mucositis and overall survival in head neck cancer patients
por: Brzozowska, Anna, et al.
Publicado: (2018)

AA genotype of PLIN1 13041A>G as an unfavourable predictive factor of malnutrition associated with fat mass loss in locally advanced head and neck cancer male patients treated with radiotherapy
por: Powrózek, Tomasz, et al.
Publicado: (2020)

Polymorphism of The Regulatory Region of the ITGAM Gene (-323G>A) as a Novel Predictor of a Poor Nutritional Status in Head and Neck Cancer Patients Subjected to Intensity-Modulated Radiation Therapy
por: Mazurek, Marcin, et al.
Publicado: (2020)

Association of Chromosome 17 Aneuploidy, TP53 Deletion, Expression and Its rs1042522 Variant with Multiple Myeloma Risk and Response to Thalidomide/Bortezomib Treatment
por: Popek-Marciniec, Sylwia, et al.
Publicado: (2023)

The Usefulness of Extended Inflammation Parameters and Systemic Inflammatory Response Markers in the Diagnostics of Autoimmune Hepatitis
por: Domerecka, Weronika, et al.
Publicado: (2022)

TNFRSF1A Gene Polymorphism (−610 T > G, rs4149570) as a Predictor of Malnutrition and a Prognostic Factor in Patients Subjected to Intensity-Modulated Radiation Therapy Due to Head and Neck Cancer
por: Homa-Mlak, Iwona, et al.
Publicado: (2022)

Predictive Value of Single Nucleotide Polymorphisms of ERCC1, XPA, XPC, XPD and XPG Genes, Involved in NER Mechanism in Patients with Advanced NSCLC Treated with Cisplatin and Gemcitabine
por: Mlak, Radosław, et al.
Publicado: (2018)

The relationship between TNF-α gene promoter polymorphism (− 1211 T > C), the plasma concentration of TNF-α, and risk of oral mucositis and shortening of overall survival in patients subjected to intensity-modulated radiation therapy due to head and neck cancer
por: Mlak, Radosław, et al.
Publicado: (2019)

High miR-511-3p Expression as a Potential Predictor of a Poor Nutritional Status in Head and Neck Cancer Patients Subjected to Intensity-Modulated Radiation Therapy
por: Mazurek, Marcin, et al.
Publicado: (2022)

Indicator of Inflammation and NETosis—Low-Density Granulocytes as a Biomarker of Autoimmune Hepatitis
por: Domerecka, Weronika, et al.
Publicado: (2022)

The Relationship of ABCB1/MDR1 and CYP1A1 Variants with the Risk of Disease Development and Shortening of Overall Survival in Patients with Multiple Myeloma
por: Zmorzynski, Szymon, et al.
Publicado: (2021)

Serum Calprotectin – a NET Product – as a Biomarker of Disease Activity in Patients with Systemic Lupus Erythematosus: A Single-Center Case-Control Study from Poland
por: Homa-Mlak, Iwona, et al.
Publicado: (2022)

Pleural Neoplasms—What Could MRI Change?
por: Szczyrek, Michał, et al.
Publicado: (2023)

Real-World Efficacy of Midostaurin in Aggressive Systemic Mastocytosis
por: Szudy-Szczyrek, Aneta, et al.
Publicado: (2021)

Impact of I/D polymorphism of ACE gene on risk of development and course of chronic obstructive pulmonary disease
por: Mlak, Radosław, et al.
Publicado: (2016)

Does Human Papillomavirus Infection Influence the Frequency and Severity of Nutritional Disorders in Head and Neck Cancer?
por: Mazurek, Marcin, et al.
Publicado: (2022)

Capacitance of Membrane As a Prognostic Indicator of Survival in Head and Neck Cancer
por: Małecka-Massalska, Teresa, et al.
Publicado: (2016)

Predictive value of STMN1 gene promoter polymorphism (−2166T>C) in patients with advanced NSCLC treated with the combination of platinum compounds and vinorelbine
por: Mlak, Radosław, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_i6cdldma1tuq6l0m6tokm9m6f2